A novel antiviral lncRNA, EDAL, shields a T309 O-GlcNAcylation site to promote EZH2 lysosomal degradation.
Sui B, Chen D, Liu W, Wu Q, Tian B, Li Y, Hou J, Liu S, Xie J, Jiang H, Luo Z, Lv L, Huang F, Li R, Zhang C, Tian Y, Cui M, Zhou M, Chen H, Fu ZF, Zhang Y, Zhao L.
Sui B, et al.
Genome Biol. 2020 Sep 1;21(1):228. doi: 10.1186/s13059-020-02150-9.
Genome Biol. 2020.
PMID: 32873321
Free PMC article.